InnovAge Appoints Jennifer Browne as President & COO to Drive Operational Improvement

summarizeSummary

InnovAge appointed Jennifer Browne as President and COO, a key hire with a strong background in value-based care and operational improvement, signaling a strategic focus on strengthening company performance.

check_boxKey Events

• New President & COO Appointed

  Jennifer Browne has been appointed President and Chief Operating Officer, effective June 8, 2026.

• Extensive Healthcare Experience

  Ms. Browne previously served as COO at Strive Health and SVP of Value & Population Health at Optum, bringing deep experience in value-based care, operational leadership, and compliance.

• Strategic Focus on Performance

  Her role will focus on driving consistent execution, enhancing participant experience, and advancing performance across operational and compliance metrics, directly addressing areas of recent company challenge.

• Comprehensive Compensation Package

  Compensation includes an annual base salary of $500,000, a $200,000 sign-on bonus, a target annual cash bonus of 75% of base salary, and annual restricted stock unit grants with a target value of $500,000, plus 1,260,000 Class B Units in TCO Group Holdings with a hurdle amount of $7.14.

auto_awesomeAnalysis

InnovAge has appointed Jennifer Browne as its new President and Chief Operating Officer. This is a significant C-suite hire, particularly given the company's recent report of increased net losses due to litigation expenses. Ms. Browne's background in value-based kidney care, operational leadership, and compliance is directly aligned with InnovAge's stated focus on disciplined execution, regulatory excellence, and sustainable growth. Her appointment signals a strategic move to strengthen core operations and enhance performance.